PFE · Pfizer Inc · Documents

$28.89 +0.06 (+0.21%) At close · Nov 13 Play latest call Q3 2026 earnings call transcript

S&P 500 member Russell 1000 member Rebalance outlook locked

Market Cap

$164.67B

5.70B

Volume · Nov 13 21.6M Avg daily vol (3M) 33.41M

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

2021

May 4

Current report 8-K

Financial results

Apr 26

Current report 8-K Events of Apr 22

Shareholder vote results

Apr 15

Proxy statement DEFA14A

Proxy statement

Mar 29

Proxy statement DEFA14A

Proxy statement

Mar 12

Proxy statement DEF 14A Meeting Apr 22, 2021

Proxy statement

Mar 12

Proxy statement DEFA14A

Proxy statement

Feb 26

Registration statement S-3ASR

Registration statement

Feb 25

Annual report 10-K FY2020, ended Dec 31

Annual report for FY2020

Revenue $41.91B ▲ 1.8% Net income $9.62B ▼ 40.9% Diluted EPS $1.71 ▼ 40.4%

Feb 2

Current report 8-K

Financial results

Feb 2

Earnings call

Q4 2020 earnings call

Jan 12

Current report 8-K

Regulation FD disclosure

2020

Dec 14

Current report 8-K

Charter or bylaw amendment, or fiscal year change

Nov 20

Current report 8-K Events of Nov 16

Completed an acquisition or sale of assets, Director or officer change, or executive pay

Nov 18

Current report 8-K

Other events

Nov 16

Current report 8-K

Regulation FD disclosure

Nov 13

Current report 8-K Events of Nov 12

Unregistered sale of equity, Charter or bylaw amendment, or fiscal year change

Nov 5

Current report 8-K

Other events

Nov 5

Quarterly report 10-Q FY2020 Q3, ended Sep 27

Quarterly report for FY2020 Q3

Revenue $12.13B ▼ 4.3% Net income $2.19B ▼ 71.4% Diluted EPS $0.39 ▼ 71.3%

Oct 30

Current report 8-K

Other events

Oct 27

Current report 8-K

Financial results

Oct 27

Earnings call

Q3 2020 earnings call

Aug 6

Current report 8-K

Regulation FD disclosure

Aug 6

Quarterly report 10-Q FY2020 Q2, ended Jun 28

Quarterly report for FY2020 Q2

Revenue $11.8B ▼ 11.0% Net income $3.43B ▼ 32.1% Diluted EPS $0.61 ▼ 31.5%

Jul 28

Current report 8-K

Financial results

Jul 28

Earnings call

Q2 2020 earnings call

Jun 26

Current report 8-K Events of Jun 22

Other events

Jun 1

Current report 8-K Events of May 29

Entered into a material agreement

May 28

Current report 8-K

Other events

May 22

Current report 8-K

Other events

May 19

Current report 8-K Events of May 18

Other events

May 7

Quarterly report 10-Q FY2020 Q1, ended Mar 29

Quarterly report for FY2020 Q1

Revenue $12.03B ▼ 8.3% Net income $3.4B ▼ 12.4% Diluted EPS $0.61 ▼ 10.3%

Apr 28

Current report 8-K

Financial results

Apr 28

Earnings call

Q1 2020 earnings call

Apr 24

Current report 8-K Events of Apr 23

Shareholder vote results

Apr 7

Proxy statement DEFA14A

Proxy statement

Apr 2

Current report 8-K Events of Apr 1

Director or officer change, or executive pay

Mar 27

Current report 8-K Events of Mar 25

Other events

Mar 13

Proxy statement DEF 14A Meeting Apr 23, 2020

Proxy statement

Mar 13

Proxy statement DEFA14A

Proxy statement

Mar 4

Current report 8-K Events of Mar 3

Director or officer change, or executive pay

Mar 2

Current report 8-K Events of Feb 27

Director or officer change, or executive pay

Feb 28

Current report 8-K Events of Feb 27

Director or officer change, or executive pay

Feb 27

Annual report 10-K FY2019, ended Dec 31

Annual report for FY2019

Revenue $51.75B ▼ 3.5% Net income $16.27B ▲ 45.9% Diluted EPS $2.87 ▲ 53.5%

Feb 11

Current report 8-K

Other events

Jan 28

Current report 8-K

Financial results

Showing 151–195 of 195 documents

Key facts CIK 78003 CUSIP 717081103 13F (30d) 2335 filings 2175 filers Visit website Investor relations